Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Drug Resistance

  Free Subscription


24.06.2019

4 Antimicrob Agents Chemother
1 Clin Infect Dis
4 Emerg Infect Dis
2 Int J Antimicrob Agents
1 J Antimicrob Chemother
4 J Infect Chemother
1 JAMA


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. LEE H, Boyle-Vavra S, Ren J, Jarusiewicz J, et al
    Identification of small molecules exhibiting oxacillin synergy through a novel assay for inhibition of vraTSR expression in methicillin resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.02593.
    PubMed     Text format     Abstract available

  2. BERKOW EL, Nunnally NS, Bandea A, Kuykendall R, et al
    Detection of TR34/L98H Cyp51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the US, 2015-2017.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02240.
    PubMed     Text format     Abstract available

  3. PARQUET MDC, Savage KA, Allan DS, Ang MTC, et al
    Antibiotic resistant Acinetobacter baumannii is susceptible to the novel iron-sequestering anti-infective DIBI in vitro and in experimental pneumonia in mice.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00855.
    PubMed     Text format     Abstract available

  4. DOLEJSKA M, Literak I
    Wildlife is overlooked in the epidemiology of medically important antimicrobial resistant bacteria.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.01167.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  5. DYMOND A, Davies H, Mealing S, Pollit V, et al
    Genomic surveillance of methicillin-resistant Staphylococcus aureus: a mathematical early modelling study of cost effectiveness.
    Clin Infect Dis. 2019 Jun 18. pii: 5521015. doi: 10.1093.
    PubMed     Text format     Abstract available


    Emerg Infect Dis

  6. MARTENS L, Kuster S, de Vos W, Kersten M, et al
    Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014-2017.
    Emerg Infect Dis. 2019;25:1297-1303.
    PubMed     Text format     Abstract available

  7. LANGELIER C, Graves M, Kalantar K, Caldera S, et al
    Microbiome and Antimicrobial Resistance Gene Dynamics in International Travelers.
    Emerg Infect Dis. 2019;25:1380-1383.
    PubMed     Text format     Abstract available

  8. RIZZO K, Horwich-Scholefield S, Epson E
    Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA(1).
    Emerg Infect Dis. 2019;25:1389-1393.
    PubMed     Text format     Abstract available

  9. WALTERS MS, Grass JE, Bulens SN, Hancock EB, et al
    Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.
    Emerg Infect Dis. 2019;25:1281-1288.
    PubMed     Text format     Abstract available


    Int J Antimicrob Agents

  10. LEE YL, Lu MC, Shao PL, Lu PL, et al
    Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria with an emphasis on carbapenems and colistin: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Int J Antimicrob Agents. 2019 Jun 13. pii: S0924-8579(19)30162.
    PubMed     Text format     Abstract available

  11. SMOKE S, Raja K, Narayanan N, Brunetti L, et al
    Selective Antibiotic Susceptibility Reporting and Broad-Spectrum Intravenous Antibiotic Use: a Multicenter Ecological Study.
    Int J Antimicrob Agents. 2019 Jun 13. pii: S0924-8579(19)30164.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  12. PITT R, Sadouki Z, Town K, Fifer H, et al
    Detection of tet(M) in high-level tetracycline-resistant Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2019;74:2115-2116.
    PubMed     Text format    


    J Infect Chemother

  13. KATO H, Yamagishi Y, Hagihara M, Yokoyama Y, et al
    Antimicrobial activity of solithromycin and levofloxacin against a murine pneumonia mixed-infection model caused by Streptococcus pneumoniae and anaerobic bacteria.
    J Infect Chemother. 2019;25:311-313.
    PubMed     Text format     Abstract available

  14. HIGA S, Sarassari R, Hamamoto K, Yakabi Y, et al
    Characterization of CTX-M type ESBL-producing Enterobacteriaceae isolated from asymptomatic healthy individuals who live in a community of the Okinawa prefecture, Japan.
    J Infect Chemother. 2019;25:314-317.
    PubMed     Text format     Abstract available

  15. KOBAYASHI I, Kanesaka I, Kanayama Katsuse A, Takahashi H, et al
    Gene expression analysis in the potent bactericidal activity of sitafloxacin against Streptococcus pneumoniae.
    J Infect Chemother. 2019;25:322-324.
    PubMed     Text format     Abstract available

  16. YAMAKAWA H, Kosai K, Akamatsu N, Matsuda J, et al
    Molecular and epidemiological analysis of IMP-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Japan.
    J Infect Chemother. 2019;25:240-246.
    PubMed     Text format     Abstract available


    JAMA

  17. FRIEDRICH MJ
    UN: All-out Effort Needed to Combat Antimicrobial Resistance.
    JAMA. 2019;321:2273.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: